FDA: Exblifep Approved for Complicated Urinary Tract Infections
Cefepime/enmetazobactam was granted a 5-year exclusivity extension under GAIN Act legislation.
Diabetes and the Skin: Complications and Prevention Tips
Skin complications are common in patients with diabetes, but pharmacists can recommend several easy measures to help.
Pharmacy in the Digital Age
The world’s information is at our fingertips, but understanding that information and applying it to patient care still requires a rigorous education.
Redefining Pharmacy Education for LGBTQ Pain Management
Academic, corporate, and clinical institutions must empower pharmacists to deliver informed and compassionate care to LGBTQ individuals that matches the standard received by their heterosexual and cisgender peers.
Stopping the Syndemic: Pharmacy at the Intersection of HIV and Injection Drug Use
As the opioid crisis and injection drug use continue, pharmacists can look to previous outbreaks to guide their responses to the HIV–injection drug use syndemic.
COVID-19 Vaccine Booster Dose Beneficial to Immunocompromised Patients
A recent study found that, of 423 participants who were initially low responders, 90% increased their antibody concentrations to more than 400 AU/mL.
Q&A: How The 2024 Election Looms Large Over Pharmacy
One of the biggest issues pharmacists are watching is the Medicare Part D redesign and copay smoothing policy.
Q&A: Navigating the Exponential Growth of Specialty Drugs
The specialty drug market has exploded in the last few decades.
Asembia: Pharmacists Have a Role in Health Care System Sustainability
As medication experts, pharmacists can advocate to organizational decision makers around the benefits of biosimilars.
Q&A: Understanding Future Impacts of the IRA
Data from 2024 are being used as a way to predict what changes may be on the way for 2025.
